• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Fischer system heads toward FDA filing

Article

Fischer Imaging of Denver is collecting the clinical data to supporta 510(k) application for its SenoScan full-view digital mammographyscanner. Fischer has placed beta SenoScan units at Brooke ArmyMedical Center in Fort Sam Houston, TX, Thomas Jefferson

Fischer Imaging of Denver is collecting the clinical data to supporta 510(k) application for its SenoScan full-view digital mammographyscanner. Fischer has placed beta SenoScan units at Brooke ArmyMedical Center in Fort Sam Houston, TX, Thomas Jefferson Universityin Philadelphia, and the University of California at San Francisco.

Fischer and other companies developing full-field systems willbe able to go the 510(k) route rather than the more rigorous premarketapproval path to obtain regulatory clearance. The FDA decidedearlier this year to allow Fischer and other companies developingfull-field digital mammography systems to submit 510(k) applicationsrather than PMA filings.

In addition to SenoScan, Fischer's RSNA booth display willinclude Performa, an ultrasound scanner for breast biopsy guidancethat Fischer has licensed from Acoustic Imaging; the MammotestPlus stereotactic breast biopsy system; and CVX, a new angiographicinterventional positioner.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.